CN1093411C - Anti-cancer medicinal composition and its preparing method - Google Patents

Anti-cancer medicinal composition and its preparing method Download PDF

Info

Publication number
CN1093411C
CN1093411C CN99111470A CN99111470A CN1093411C CN 1093411 C CN1093411 C CN 1093411C CN 99111470 A CN99111470 A CN 99111470A CN 99111470 A CN99111470 A CN 99111470A CN 1093411 C CN1093411 C CN 1093411C
Authority
CN
China
Prior art keywords
radix
cancer
medicine
realgar
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN99111470A
Other languages
Chinese (zh)
Other versions
CN1290550A (en
Inventor
丁进周
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YANGGUANG PHARMACEUTICAL CO Ltd SHIJIAZHUANG
Original Assignee
YANGGUANG PHARMACEUTICAL CO Ltd SHIJIAZHUANG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YANGGUANG PHARMACEUTICAL CO Ltd SHIJIAZHUANG filed Critical YANGGUANG PHARMACEUTICAL CO Ltd SHIJIAZHUANG
Priority to CN99111470A priority Critical patent/CN1093411C/en
Publication of CN1290550A publication Critical patent/CN1290550A/en
Application granted granted Critical
Publication of CN1093411C publication Critical patent/CN1093411C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention belongs to a compound traditional Chinese medicine preparation, particularly to an anticancer medicine and a preparation thereof. The medicine is mainly composed of medicines of milkvetch root, angelica, red peony root, red sage root, hemlock parsley, phellodendron bark, pear, honeycomb, alum, realgar, borneol, etc. The medicine can obviously increase human immune function, has obvious therapeutic effect on pancreatic cancer, esophagus cancer, stomach cancer and lung cancer, and can improve symptoms of cancer patients, reduce turgescence until the turgescence is eliminated, subsidiarily increase the therapeutic effects of radiotherapy and chemotherapy, reduce toxicity and decrease the relapse rate.

Description

A kind of anticancer pharmaceutical composition and preparation method thereof
The invention belongs to composite Chinese medicine preparation, be meant a kind of composition and method of making the same of cancer therapy drug especially.
Treatment for cancer is in the still manque method of medical circle at present.Traditional western medical treatment adopts operation, three kinds of modes that combine of chemotherapy and radiation more, and its drawback is more, and it when suppressing tumor growth, has also greatly destroyed the normal cell tissue on the one hand, has caused bigger misery to patient.Chinese medicine is China's traditional medicine, there are many inventors to invent the Chinese medicine anticancer drugs in recent years, but great majority are that adopting based on the treating the poisonous disease with poisonous drugs of attacking, hard masses softening and resolving, activating blood circulation to dissipate blood stasis, the dissipating depression of QI that eliminates the phlegm etc. is the prescription product of the rule of treatment, as " Tianxian Capsule ", " esophagus is peaceful " of Shanxi product in Tonghua, more influential Jilin, " the imperial tongue piece " in Hong Kong or the like.
The object of the present invention is to provide a kind of can significantly improve body three exempt from service greatly function, good cancer suppressing action and cancer therapy drug without any side effects and preparation method thereof are arranged.
Drug component of the present invention is:
Radix Astragali 200-350 Radix Angelicae Sinensis 100-200 Radix Paeoniae Rubra 30-100 Radix Salviae Miltiorrhizae 80-140
Rhizoma Chuanxiong 30-60 Cortex Phellodendri 40-120 Margarita 15-40 Nidus Vespae 15-40
Alumen 4-15 Realgar 4-15 Borneolum Syntheticum 0.002-0.04.
Preparation method of the present invention is: Radix Angelicae Sinensis, Rhizoma Chuanxiong, Alumen, Realgar, Margarita powder are broken into the above fine powder of 100 orders, and standby.The Radix Astragali, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Nidus Vespae, Cortex Phellodendri five kinds of Chinese medicine are added the 60-80% alcohol reflux more than twice, be no less than 1 hour at every turn, filter.Merging filtrate, decompression recycling ethanol becomes extractum, and medicinal residues decoct with water twice, each 3 hours, filter, filtrate and above-mentioned extractum merge, being evaporated to 50 ℃ of heat survey relative densities is the thick paste of 1.30-1.35, and 60 ℃ of dryings are pulverized with the medical material fine powder and are mixed and made into granule.Borneolum Syntheticum is dissolved in an amount of ethanol, evenly is sprayed on the granule, and mixing, cold drying, promptly encapsulated.
The present invention is described in further detail below in conjunction with embodiment:
The component content of each medicine is in the present embodiment:
Radix Astragali 280g Radix Angelicae Sinensis 140g Radix Paeoniae Rubra 80g Radix Salviae Miltiorrhizae 108g Rhizoma Chuanxiong 48g
Cortex Phellodendri 80g Margarita 28g Nidus Vespae 20g Alumen 8g Realgar 8g
Borneolum Syntheticum 0.004g.
Preparation method: earlier Radix Angelicae Sinensis, Rhizoma Chuanxiong, Alumen, Realgar, Margarita powder are broken into 120 order fine powders, the Radix Astragali, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Nidus Vespae, Cortex Phellodendri five kinds of Chinese medicine are added 70% alcohol reflux more than twice, each 1 hour, filter.Merging filtrate, decompression recycling ethanol becomes extractum, and medicinal residues decoct with water twice, each 3 hours, filter, filtrate and above-mentioned extractum merge, being evaporated to 50 ℃ of heat survey relative densities is the thick paste of 1.30-1.35,60 ℃ of dryings are pulverized with the medical material fine powder and are mixed and made into granule, and Borneolum Syntheticum is dissolved in an amount of ethanol, evenly be sprayed on the granule, mixing, cold drying, promptly encapsulated.In this medicine components, with the Radix Astragali, Radix Angelicae Sinensis benefiting vital QI and blood, it is monarch that strengthening vital QI to eliminate pathogenic factors presses down tumor, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Rhizoma Chuanxiong activating blood circulation to dissipate blood stasis, and activating collaterals and eliminating stagnation, eliminating mass is removed the long-pending minister that is.Margarita is sweet salty, the detoxifcation softening the hard mass, and the Nidus Vespae counteracting toxic substances, the swollen pain relieving of loosing, Alumen is sour and astringent, dampness is weighed down turbid reducing phlegm, and promoting the production of body fluid is rotten, and meat is disliked in erosion, gives birth to good meat.Realgar detoxifcation is loose long-pending, the Cortex Phellodendri bitter cold, and the heat clearing away consolidating YIN, five medicines make with the Borneolum Syntheticum acrid in the mouth for assistant, and fragrance is walked to scurry, the collateral dredging of having one's ideas straightened out, the priming tumor whereabouts that goes directly, all medicines close and associate with.It gathers benefiting QI and nourishing blood, changes the silt removing food stagnancy, hard masses softening and resolving, and detoxifcation is weighed down turbid, eliminates the merit of tumor.
The obtained technological progress of the present invention is:
It is main body that the present invention uses the antitumor rules for the treatment of of the traditional Chinese medical science " reinforcing method is this ", whole from traditional Chinese medicine The body idea is set out, and thinks that the tumour illness is the topical manifestations of human lesion, and the human body internal cause is exempted from service surely Deciding function relatively lowly is to cause tumorigenic principal element. Adjusting, excited, enhancing tumour Patient's body function of exempting from service just can suppress tumor growth, even cures tumour. Experiment is demonstrate,proved in addition Bright the present invention is especially remarkable to cancer of pancreas, cancer of the esophagus, cancer of the stomach, oncotherapy effect, and can protect Protect sex resistance by the hematopoietic disorder due to radiotherapy, the chemotherapy, reduce toxicity due to the Radiotherapy chemotherapy.

Claims (2)

1, a kind of anticancer pharmaceutical composition is characterized in that: it is to be made by following materials of weight proportions:
Radix Astragali 200-350 Radix Angelicae Sinensis 100-200 Radix Paeoniae Rubra 30-100
Radix Salviae Miltiorrhizae 80-140 Rhizoma Chuanxiong 30-60 Cortex Phellodendri 40-120
Margarita 15-40 Nidus Vespae 15-40 Alumen 4-15
Realgar 4-15 Borneolum Syntheticum 0.002-0.04.
2, the preparation method of a kind of anticancer pharmaceutical composition according to claim 1, it is characterized in that: with Radix Angelicae Sinensis, Rhizoma Chuanxiong, Alumen, Realgar, Margarita powder is broken into the above fine powder of 100 orders, with the Radix Astragali, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Nidus Vespae, the Cortex Phellodendri five kinds of Chinese medicine adds the 60-80% alcohol reflux more than twice, be no less than 1 hour at every turn, filter, merging filtrate, decompression recycling ethanol becomes extractum, and medicinal residues decoct with water twice, each 3 hours, filter, filtrate and above-mentioned extractum merge, and being evaporated to 50 ℃ of heat survey relative densities is the thick paste of 1.30-1.45,60 ℃ of dryings, pulverize with the medical material fine powder and be mixed and made into granule, Borneolum Syntheticum is dissolved in an amount of ethanol, evenly is sprayed on the granule mixing, cold drying, encapsulated.
CN99111470A 1999-08-17 1999-08-17 Anti-cancer medicinal composition and its preparing method Expired - Fee Related CN1093411C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99111470A CN1093411C (en) 1999-08-17 1999-08-17 Anti-cancer medicinal composition and its preparing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99111470A CN1093411C (en) 1999-08-17 1999-08-17 Anti-cancer medicinal composition and its preparing method

Publications (2)

Publication Number Publication Date
CN1290550A CN1290550A (en) 2001-04-11
CN1093411C true CN1093411C (en) 2002-10-30

Family

ID=5275111

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99111470A Expired - Fee Related CN1093411C (en) 1999-08-17 1999-08-17 Anti-cancer medicinal composition and its preparing method

Country Status (1)

Country Link
CN (1) CN1093411C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101361789B (en) * 2008-09-28 2011-07-27 中国人民解放军第四军医大学 Traditional Chinese medicine formulation for treating and preventing lung impairment after tumor controlling radiotherapy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
福建中医药93,24(6) 1993.1.1 吴清都 启膈汤治疗食管癌咽下因难症36例 *

Also Published As

Publication number Publication date
CN1290550A (en) 2001-04-11

Similar Documents

Publication Publication Date Title
CN1315525C (en) Chinese traditional medicine for treating breast disease and preparing technique
CN101181529B (en) Chinese medicine composition for curing tumor and preparation method thereof
CN100528211C (en) Traditional Chinese medicine for treating tumor
CN105362340B (en) A kind of pharmaceutical composition for treating leukaemia and preparation method thereof
CN103127326A (en) Pharmaceutical composition for treating osteoarthritis and preparation method thereof
CN1082376C (en) Pathogenic factor eliminating and healthy energy supporting anticancer medicine
CN1093411C (en) Anti-cancer medicinal composition and its preparing method
CN1883642A (en) Medicine for treating mammary glands hyperplasia
CN1081045C (en) Anti-cancer medicine and its preparing method
CN101979035A (en) Medicament for treating gynecological abnormal leucorrhea
CN1593566A (en) Hemiplegia treating pill
CN1144595C (en) Anticancer capsule
CN111388564B (en) Traditional Chinese medicine for treating bradyarrhythmia
CN101239140A (en) Chinese medicine for treating psoriasis
CN1263479C (en) Chinese traditional medicine for treating cardiopathy
CN104398975A (en) Traditional Chinese medicinal preparation for treating fibroadenoma of breast and preparation method thereof
CN100340272C (en) Headache-treating medicine
CN110123896B (en) Pharmaceutical composition for adjuvant treatment of tumor and preparation method thereof
CN1167440C (en) Chinese herbal medicine composition for smoothing the liver and detoxication
CN101352496A (en) Traditional Chinese medicine for treating hepatitis
CN1836705A (en) Medicine for treating amblyopia and its preparing method
CN104784547A (en) Traditional Chinese medicine composition having synergistic effect on radiotherapy and preparation method
CN118217370A (en) Compound taxol broad-spectrum anticancer Chinese medicinal preparation and its preparation method
CN1199632A (en) Chinese medicine preparation as adjuvant for chemotherapy of tumour and its preparation process
CN105521150A (en) Preparation method traditional Chinese medicine for reducing blood fat

Legal Events

Date Code Title Description
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Yangguang Pharmaceutical Co., Ltd., Shijiazhuang

Document name: Correction notice

C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Zhao Fulai

Document name: payment instructions

C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee